Global Sustained and Controlled Release Formulations Market Growth 2022-2028
The global market for Sustained and Controlled Release Formulations is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Sustained and Controlled Release Formulations players cover Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Qilu Pharmaceutical Co Ltd and Shanghai Pharmaceuticals Holding Co.,Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Sustained and Controlled Release Formulations market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Sustained and Controlled Release Formulations market, with both quantitative and qualitative data, to help readers understand how the Sustained and Controlled Release Formulations market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Sustained and Controlled Release Formulations market and forecasts the market size by Type (Generic Drug and Original Drug,), by Application (Cardiovascular System Drugs, Nervous System Drugs, Digestive System and Metabolism and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Generic Drug
Original Drug
Segmentation by application
Cardiovascular System Drugs
Nervous System Drugs
Digestive System and Metabolism
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Humanwell Healthcare Co.,Ltd.
Nanjing Yiheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
Qilu Pharmaceutical Co Ltd
Shanghai Pharmaceuticals Holding Co.,Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
PKU HealthCare Corp.,Ltd.
Overseas Pharmaceuticals, Ltd.
Novast Laboratories (China), LTD.
Catalent
AstraZeneca Plc
Oakwood Labs
Ascendia Pharma
Colorcon
Pfizer Inc.
Mylan
Sandoz
Chapter Introduction
Chapter 1: Scope of Sustained and Controlled Release Formulations, Research Methodology, etc.
Chapter 2: Executive Summary, global Sustained and Controlled Release Formulations market size (sales and revenue) and CAGR, Sustained and Controlled Release Formulations market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Sustained and Controlled Release Formulations sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Sustained and Controlled Release Formulations sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Sustained and Controlled Release Formulations market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Qilu Pharmaceutical Co Ltd, Shanghai Pharmaceuticals Holding Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., PKU HealthCare Corp.,Ltd., Overseas Pharmaceuticals, Ltd. and Novast Laboratories (China), LTD., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sustained and Controlled Release Formulations Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sustained and Controlled Release Formulations by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sustained and Controlled Release Formulations by Country/Region, 2017, 2022 & 2028
2.2 Sustained and Controlled Release Formulations Segment by Type
2.2.1 Generic Drug
2.2.2 Original Drug
2.3 Sustained and Controlled Release Formulations Sales by Type
2.3.1 Global Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
2.3.2 Global Sustained and Controlled Release Formulations Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sustained and Controlled Release Formulations Sale Price by Type (2017-2022)
2.4 Sustained and Controlled Release Formulations Segment by Application
2.4.1 Cardiovascular System Drugs
2.4.2 Nervous System Drugs
2.4.3 Digestive System and Metabolism
2.4.4 Other
2.5 Sustained and Controlled Release Formulations Sales by Application
2.5.1 Global Sustained and Controlled Release Formulations Sale Market Share by Application (2017-2022)
2.5.2 Global Sustained and Controlled Release Formulations Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sustained and Controlled Release Formulations Sale Price by Application (2017-2022)
3 Global Sustained and Controlled Release Formulations by Company
3.1 Global Sustained and Controlled Release Formulations Breakdown Data by Company
3.1.1 Global Sustained and Controlled Release Formulations Annual Sales by Company (2020-2022)
3.1.2 Global Sustained and Controlled Release Formulations Sales Market Share by Company (2020-2022)
3.2 Global Sustained and Controlled Release Formulations Annual Revenue by Company (2020-2022)
3.2.1 Global Sustained and Controlled Release Formulations Revenue by Company (2020-2022)
3.2.2 Global Sustained and Controlled Release Formulations Revenue Market Share by Company (2020-2022)
3.3 Global Sustained and Controlled Release Formulations Sale Price by Company
3.4 Key Manufacturers Sustained and Controlled Release Formulations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sustained and Controlled Release Formulations Product Location Distribution
3.4.2 Players Sustained and Controlled Release Formulations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sustained and Controlled Release Formulations by Geographic Region
4.1 World Historic Sustained and Controlled Release Formulations Market Size by Geographic Region (2017-2022)
4.1.1 Global Sustained and Controlled Release Formulations Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sustained and Controlled Release Formulations Annual Revenue by Geographic Region
4.2 World Historic Sustained and Controlled Release Formulations Market Size by Country/Region (2017-2022)
4.2.1 Global Sustained and Controlled Release Formulations Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sustained and Controlled Release Formulations Annual Revenue by Country/Region
4.3 Americas Sustained and Controlled Release Formulations Sales Growth
4.4 APAC Sustained and Controlled Release Formulations Sales Growth
4.5 Europe Sustained and Controlled Release Formulations Sales Growth
4.6 Middle East & Africa Sustained and Controlled Release Formulations Sales Growth
5 Americas
5.1 Americas Sustained and Controlled Release Formulations Sales by Country
5.1.1 Americas Sustained and Controlled Release Formulations Sales by Country (2017-2022)
5.1.2 Americas Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
5.2 Americas Sustained and Controlled Release Formulations Sales by Type
5.3 Americas Sustained and Controlled Release Formulations Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sustained and Controlled Release Formulations Sales by Region
6.1.1 APAC Sustained and Controlled Release Formulations Sales by Region (2017-2022)
6.1.2 APAC Sustained and Controlled Release Formulations Revenue by Region (2017-2022)
6.2 APAC Sustained and Controlled Release Formulations Sales by Type
6.3 APAC Sustained and Controlled Release Formulations Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sustained and Controlled Release Formulations by Country
7.1.1 Europe Sustained and Controlled Release Formulations Sales by Country (2017-2022)
7.1.2 Europe Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
7.2 Europe Sustained and Controlled Release Formulations Sales by Type
7.3 Europe Sustained and Controlled Release Formulations Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sustained and Controlled Release Formulations by Country
8.1.1 Middle East & Africa Sustained and Controlled Release Formulations Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
8.2 Middle East & Africa Sustained and Controlled Release Formulations Sales by Type
8.3 Middle East & Africa Sustained and Controlled Release Formulations Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sustained and Controlled Release Formulations
10.3 Manufacturing Process Analysis of Sustained and Controlled Release Formulations
10.4 Industry Chain Structure of Sustained and Controlled Release Formulations
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sustained and Controlled Release Formulations Distributors
11.3 Sustained and Controlled Release Formulations Customer
12 World Forecast Review for Sustained and Controlled Release Formulations by Geographic Region
12.1 Global Sustained and Controlled Release Formulations Market Size Forecast by Region
12.1.1 Global Sustained and Controlled Release Formulations Forecast by Region (2023-2028)
12.1.2 Global Sustained and Controlled Release Formulations Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sustained and Controlled Release Formulations Forecast by Type
12.7 Global Sustained and Controlled Release Formulations Forecast by Application
13 Key Players Analysis
13.1 Humanwell Healthcare Co.,Ltd.
13.1.1 Humanwell Healthcare Co.,Ltd. Company Information
13.1.2 Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Product Offered
13.1.3 Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Humanwell Healthcare Co.,Ltd. Main Business Overview
13.1.5 Humanwell Healthcare Co.,Ltd. Latest Developments
13.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
13.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
13.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Product Offered
13.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
13.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Product Offered
13.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.4 Qilu Pharmaceutical Co Ltd
13.4.1 Qilu Pharmaceutical Co Ltd Company Information
13.4.2 Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Product Offered
13.4.3 Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Qilu Pharmaceutical Co Ltd Main Business Overview
13.4.5 Qilu Pharmaceutical Co Ltd Latest Developments
13.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
13.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
13.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Product Offered
13.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Main Business Overview
13.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Latest Developments
13.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Product Offered
13.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.7 PKU HealthCare Corp.,Ltd.
13.7.1 PKU HealthCare Corp.,Ltd. Company Information
13.7.2 PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Product Offered
13.7.3 PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PKU HealthCare Corp.,Ltd. Main Business Overview
13.7.5 PKU HealthCare Corp.,Ltd. Latest Developments
13.8 Overseas Pharmaceuticals, Ltd.
13.8.1 Overseas Pharmaceuticals, Ltd. Company Information
13.8.2 Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Product Offered
13.8.3 Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Overseas Pharmaceuticals, Ltd. Main Business Overview
13.8.5 Overseas Pharmaceuticals, Ltd. Latest Developments
13.9 Novast Laboratories (China), LTD.
13.9.1 Novast Laboratories (China), LTD. Company Information
13.9.2 Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Product Offered
13.9.3 Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novast Laboratories (China), LTD. Main Business Overview
13.9.5 Novast Laboratories (China), LTD. Latest Developments
13.10 Catalent
13.10.1 Catalent Company Information
13.10.2 Catalent Sustained and Controlled Release Formulations Product Offered
13.10.3 Catalent Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Catalent Main Business Overview
13.10.5 Catalent Latest Developments
13.11 AstraZeneca Plc
13.11.1 AstraZeneca Plc Company Information
13.11.2 AstraZeneca Plc Sustained and Controlled Release Formulations Product Offered
13.11.3 AstraZeneca Plc Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AstraZeneca Plc Main Business Overview
13.11.5 AstraZeneca Plc Latest Developments
13.12 Oakwood Labs
13.12.1 Oakwood Labs Company Information
13.12.2 Oakwood Labs Sustained and Controlled Release Formulations Product Offered
13.12.3 Oakwood Labs Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Oakwood Labs Main Business Overview
13.12.5 Oakwood Labs Latest Developments
13.13 Ascendia Pharma
13.13.1 Ascendia Pharma Company Information
13.13.2 Ascendia Pharma Sustained and Controlled Release Formulations Product Offered
13.13.3 Ascendia Pharma Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ascendia Pharma Main Business Overview
13.13.5 Ascendia Pharma Latest Developments
13.14 Colorcon
13.14.1 Colorcon Company Information
13.14.2 Colorcon Sustained and Controlled Release Formulations Product Offered
13.14.3 Colorcon Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Colorcon Main Business Overview
13.14.5 Colorcon Latest Developments
13.15 Pfizer Inc.
13.15.1 Pfizer Inc. Company Information
13.15.2 Pfizer Inc. Sustained and Controlled Release Formulations Product Offered
13.15.3 Pfizer Inc. Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Pfizer Inc. Main Business Overview
13.15.5 Pfizer Inc. Latest Developments
13.16 Mylan
13.16.1 Mylan Company Information
13.16.2 Mylan Sustained and Controlled Release Formulations Product Offered
13.16.3 Mylan Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Mylan Main Business Overview
13.16.5 Mylan Latest Developments
13.17 Sandoz
13.17.1 Sandoz Company Information
13.17.2 Sandoz Sustained and Controlled Release Formulations Product Offered
13.17.3 Sandoz Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sandoz Main Business Overview
13.17.5 Sandoz Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Sustained and Controlled Release Formulations Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sustained and Controlled Release Formulations Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Generic Drug
Table 4. Major Players of Original Drug
Table 5. Global Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 6. Global Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 7. Global Sustained and Controlled Release Formulations Revenue by Type (2017-2022) & ($ million)
Table 8. Global Sustained and Controlled Release Formulations Revenue Market Share by Type (2017-2022)
Table 9. Global Sustained and Controlled Release Formulations Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 11. Global Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 12. Global Sustained and Controlled Release Formulations Revenue by Application (2017-2022)
Table 13. Global Sustained and Controlled Release Formulations Revenue Market Share by Application (2017-2022)
Table 14. Global Sustained and Controlled Release Formulations Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Sustained and Controlled Release Formulations Sales by Company (2020-2022) & (K Units)
Table 16. Global Sustained and Controlled Release Formulations Sales Market Share by Company (2020-2022)
Table 17. Global Sustained and Controlled Release Formulations Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Sustained and Controlled Release Formulations Revenue Market Share by Company (2020-2022)
Table 19. Global Sustained and Controlled Release Formulations Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Sustained and Controlled Release Formulations Producing Area Distribution and Sales Area
Table 21. Players Sustained and Controlled Release Formulations Products Offered
Table 22. Sustained and Controlled Release Formulations Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sustained and Controlled Release Formulations Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Sustained and Controlled Release Formulations Sales Market Share Geographic Region (2017-2022)
Table 27. Global Sustained and Controlled Release Formulations Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Sustained and Controlled Release Formulations Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Sustained and Controlled Release Formulations Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Sustained and Controlled Release Formulations Sales Market Share by Country/Region (2017-2022)
Table 31. Global Sustained and Controlled Release Formulations Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Sustained and Controlled Release Formulations Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 34. Americas Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 35. Americas Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 37. Americas Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 38. Americas Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 39. Americas Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 40. Americas Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 41. APAC Sustained and Controlled Release Formulations Sales by Region (2017-2022) & (K Units)
Table 42. APAC Sustained and Controlled Release Formulations Sales Market Share by Region (2017-2022)
Table 43. APAC Sustained and Controlled Release Formulations Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Sustained and Controlled Release Formulations Revenue Market Share by Region (2017-2022)
Table 45. APAC Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 46. APAC Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 47. APAC Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 48. APAC Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 49. Europe Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 50. Europe Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 51. Europe Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 53. Europe Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 54. Europe Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 55. Europe Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 56. Europe Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Sustained and Controlled Release Formulations
Table 66. Key Market Challenges & Risks of Sustained and Controlled Release Formulations
Table 67. Key Industry Trends of Sustained and Controlled Release Formulations
Table 68. Sustained and Controlled Release Formulations Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sustained and Controlled Release Formulations Distributors List
Table 71. Sustained and Controlled Release Formulations Customer List
Table 72. Global Sustained and Controlled Release Formulations Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Sustained and Controlled Release Formulations Sales Market Forecast by Region
Table 74. Global Sustained and Controlled Release Formulations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Sustained and Controlled Release Formulations Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Sustained and Controlled Release Formulations Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Sustained and Controlled Release Formulations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Sustained and Controlled Release Formulations Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Sustained and Controlled Release Formulations Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Sustained and Controlled Release Formulations Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Sustained and Controlled Release Formulations Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Sustained and Controlled Release Formulations Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Sustained and Controlled Release Formulations Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Sustained and Controlled Release Formulations Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Sustained and Controlled Release Formulations Revenue Market Share Forecast by Application (2023-2028)
Table 92. Humanwell Healthcare Co.,Ltd. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 93. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Product Offered
Table 94. Humanwell Healthcare Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Humanwell Healthcare Co.,Ltd. Main Business
Table 96. Humanwell Healthcare Co.,Ltd. Latest Developments
Table 97. Nanjing Yiheng Pharmaceutical Co., Ltd. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 98. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Product Offered
Table 99. Nanjing Yiheng Pharmaceutical Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business
Table 101. Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
Table 102. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 103. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Product Offered
Table 104. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 106. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 107. Qilu Pharmaceutical Co Ltd Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 108. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Product Offered
Table 109. Qilu Pharmaceutical Co Ltd Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Qilu Pharmaceutical Co Ltd Main Business
Table 111. Qilu Pharmaceutical Co Ltd Latest Developments
Table 112. Shanghai Pharmaceuticals Holding Co.,Ltd. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 113. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Product Offered
Table 114. Shanghai Pharmaceuticals Holding Co.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Shanghai Pharmaceuticals Holding Co.,Ltd. Main Business
Table 116. Shanghai Pharmaceuticals Holding Co.,Ltd. Latest Developments
Table 117. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 118. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Product Offered
Table 119. Yangtze River Pharmaceutical (Group) Co., Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 121. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 122. PKU HealthCare Corp.,Ltd. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 123. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Product Offered
Table 124. PKU HealthCare Corp.,Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. PKU HealthCare Corp.,Ltd. Main Business
Table 126. PKU HealthCare Corp.,Ltd. Latest Developments
Table 127. Overseas Pharmaceuticals, Ltd. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 128. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Product Offered
Table 129. Overseas Pharmaceuticals, Ltd. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Overseas Pharmaceuticals, Ltd. Main Business
Table 131. Overseas Pharmaceuticals, Ltd. Latest Developments
Table 132. Novast Laboratories (China), LTD. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 133. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Product Offered
Table 134. Novast Laboratories (China), LTD. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Novast Laboratories (China), LTD. Main Business
Table 136. Novast Laboratories (China), LTD. Latest Developments
Table 137. Catalent Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 138. Catalent Sustained and Controlled Release Formulations Product Offered
Table 139. Catalent Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Catalent Main Business
Table 141. Catalent Latest Developments
Table 142. AstraZeneca Plc Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 143. AstraZeneca Plc Sustained and Controlled Release Formulations Product Offered
Table 144. AstraZeneca Plc Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. AstraZeneca Plc Main Business
Table 146. AstraZeneca Plc Latest Developments
Table 147. Oakwood Labs Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 148. Oakwood Labs Sustained and Controlled Release Formulations Product Offered
Table 149. Oakwood Labs Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Oakwood Labs Main Business
Table 151. Oakwood Labs Latest Developments
Table 152. Ascendia Pharma Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 153. Ascendia Pharma Sustained and Controlled Release Formulations Product Offered
Table 154. Ascendia Pharma Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Ascendia Pharma Main Business
Table 156. Ascendia Pharma Latest Developments
Table 157. Colorcon Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 158. Colorcon Sustained and Controlled Release Formulations Product Offered
Table 159. Colorcon Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Colorcon Main Business
Table 161. Colorcon Latest Developments
Table 162. Pfizer Inc. Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 163. Pfizer Inc. Sustained and Controlled Release Formulations Product Offered
Table 164. Pfizer Inc. Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Pfizer Inc. Main Business
Table 166. Pfizer Inc. Latest Developments
Table 167. Mylan Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 168. Mylan Sustained and Controlled Release Formulations Product Offered
Table 169. Mylan Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Mylan Main Business
Table 171. Mylan Latest Developments
Table 172. Sandoz Basic Information, Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 173. Sandoz Sustained and Controlled Release Formulations Product Offered
Table 174. Sandoz Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Sandoz Main Business
Table 176. Sandoz Latest Developments
List of Figures
Figure 1. Picture of Sustained and Controlled Release Formulations
Figure 2. Sustained and Controlled Release Formulations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sustained and Controlled Release Formulations Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Sustained and Controlled Release Formulations Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sustained and Controlled Release Formulations Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Generic Drug
Figure 10. Product Picture of Original Drug
Figure 11. Global Sustained and Controlled Release Formulations Sales Market Share by Type in 2021
Figure 12. Global Sustained and Controlled Release Formulations Revenue Market Share by Type (2017-2022)
Figure 13. Sustained and Controlled Release Formulations Consumed in Cardiovascular System Drugs
Figure 14. Global Sustained and Controlled Release Formulations Market: Cardiovascular System Drugs (2017-2022) & (K Units)
Figure 15. Sustained and Controlled Release Formulations Consumed in Nervous System Drugs
Figure 16. Global Sustained and Controlled Release Formulations Market: Nervous System Drugs (2017-2022) & (K Units)
Figure 17. Sustained and Controlled Release Formulations Consumed in Digestive System and Metabolism
Figure 18. Global Sustained and Controlled Release Formulations Market: Digestive System and Metabolism (2017-2022) & (K Units)
Figure 19. Sustained and Controlled Release Formulations Consumed in Other
Figure 20. Global Sustained and Controlled Release Formulations Market: Other (2017-2022) & (K Units)
Figure 21. Global Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Figure 22. Global Sustained and Controlled Release Formulations Revenue Market Share by Application in 2021
Figure 23. Sustained and Controlled Release Formulations Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Sustained and Controlled Release Formulations Revenue Market Share by Company in 2021
Figure 25. Global Sustained and Controlled Release Formulations Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Sustained and Controlled Release Formulations Revenue Market Share by Geographic Region in 2021
Figure 27. Global Sustained and Controlled Release Formulations Sales Market Share by Region (2017-2022)
Figure 28. Global Sustained and Controlled Release Formulations Revenue Market Share by Country/Region in 2021
Figure 29. Americas Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 30. Americas Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 31. APAC Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 32. APAC Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 33. Europe Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 34. Europe Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 37. Americas Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 38. Americas Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 39. United States Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Sustained and Controlled Release Formulations Sales Market Share by Region in 2021
Figure 44. APAC Sustained and Controlled Release Formulations Revenue Market Share by Regions in 2021
Figure 45. China Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 52. Europe Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 53. Germany Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 60. Egypt Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Sustained and Controlled Release Formulations in 2021
Figure 66. Manufacturing Process Analysis of Sustained and Controlled Release Formulations
Figure 67. Industry Chain Structure of Sustained and Controlled Release Formulations
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets